One of New Zealand’s biggest period care brands has been acquired by Somedays, the Canadian natural period pain relief firm. AWWA Periodcare, which specialises in reusable,...
A leader at the heart of the dating app revolution of recent decades has joined the board of Europe’s first femtech unicorn Flo Health. Mandy Ginsberg,...
A femtech venture focused on better supporting the one in three women affected by chronic hormonal conditions has been backed by US$26m in funding. Allara Health...
Women are no strangers to decision fatigue. From navigating reproductive health to managing chronic conditions and making daily lifestyle choices, the sheer volume of decisions women...
Rapid development of the science behind in-vitro gametes (IVGs) – sperm or eggs created genetically from reprogrammed skin or stem cells – has prompted the UK’s...
AI Super Agents: What They Are and Their Potential Global Health Impact Artificial General Intelligence (AGI) represents a significant advancement in AI, with the potential to...
Post-traumatic stress disorder and anxiety are associated with lower levels of anti-Müllerian hormone, a marker of ovarian reserve, among women firefighters, new research has found. The...
SiS Solve, a global leader in driving innovation within women’s health, has announced the launch of SiS Solve New York 2025, a pitch event offering over...
Innovative Birmingham-based nutrition firm Rem3dy Health has been recognised in the first-ever “Sunday Times 100 Tech: Britain’s fastest-growing private technology companies” list. The new rankings were...
A clinical trial has found that, in patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of...
